Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-24-023215

Options or other derivatives

  • Director acquired 1,764 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Papapetropoulos Spyros Director 2024-06-05 Grant or award · Stock Option (Right to Buy) +1,764 $7.05 $12,436 5,410 D: show line 1 in the form
Loading xslF345X05/ownership.xml…